About

Treatment Registry records GLP-1 treatment programs as they are actually sold, with the date and the source for every figure, and keeps every reading so the record accumulates a history instead of overwriting one.

Prices in this market move often and quietly. A review written once and left alone stops being true within weeks, and nothing public records what a program cost last quarter. That is the gap this register exists to fill: 1139 entries across 436 companies, each re-read on a schedule, each change dated.

What it is not

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

Who writes it

Treatment Registry is the organization responsible for this research. We inspect published offers, preserve dated source quotes, and explain what the evidence does and does not establish. We do not claim clinical review or personal treatment experience. Each record links to the source a reader can check, and corrections remain visible in its history.

Treatment Registry is published by Katalys Affiliates. How it is funded is set out in full on the disclosure page, and the method is on how entries are recorded.

Using the data

The whole register is downloadable as CSV or JSON under a Creative Commons Attribution license, and every entry page carries a citation line with its retrieval date. See the data page. Corrections are welcome and are handled as a new dated reading rather than a silent edit.

The terms of use set out what we do and do not warrant about the record, and the privacy page covers the little we collect. Corrections go to corrections@treatmentregistry.com.